NL8005072A - Werkwijze ter bereiding van een antibioticum. - Google Patents

Werkwijze ter bereiding van een antibioticum. Download PDF

Info

Publication number
NL8005072A
NL8005072A NL8005072A NL8005072A NL8005072A NL 8005072 A NL8005072 A NL 8005072A NL 8005072 A NL8005072 A NL 8005072A NL 8005072 A NL8005072 A NL 8005072A NL 8005072 A NL8005072 A NL 8005072A
Authority
NL
Netherlands
Prior art keywords
sodium salt
fur
acetoxymethyl
solution
water
Prior art date
Application number
NL8005072A
Other languages
English (en)
Dutch (nl)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8005072A publication Critical patent/NL8005072A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
NL8005072A 1979-09-10 1980-09-09 Werkwijze ter bereiding van een antibioticum. NL8005072A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7931379 1979-09-10
GB7931379 1979-09-10

Publications (1)

Publication Number Publication Date
NL8005072A true NL8005072A (nl) 1981-03-12

Family

ID=10507735

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8005072A NL8005072A (nl) 1979-09-10 1980-09-09 Werkwijze ter bereiding van een antibioticum.

Country Status (12)

Country Link
US (1) US4341777A (da)
JP (1) JPS5645486A (da)
AU (1) AU6216080A (da)
BE (1) BE885143A (da)
DE (1) DE3033868A1 (da)
DK (1) DK382580A (da)
FR (1) FR2464960A1 (da)
GB (1) GB2061922B (da)
IT (1) IT1128177B (da)
NL (1) NL8005072A (da)
NZ (1) NZ194895A (da)
ZA (1) ZA805556B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
US6930983B2 (en) * 2000-03-15 2005-08-16 Texas Instruments Incorporated Integrated circuits, systems, apparatus, packets and processes utilizing path diversity for media over packet applications
US6911441B2 (en) 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
EP3764485A1 (en) 2019-07-12 2021-01-13 Ratier-Figeac SAS Brush assembly

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974153A (en) * 1971-05-14 1976-08-10 Glaxo Laboratories Limited 7-Hydrocarbonoxy imino-acetamido-3-carbamoyloxy methylceph-3-em-4 carboxylic acids
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
FR2414509A1 (fr) * 1978-01-17 1979-08-10 Glaxo Group Ltd Procede de cristallisation de cefuroxime sodique

Also Published As

Publication number Publication date
GB2061922A (en) 1981-05-20
BE885143A (fr) 1981-03-09
IT8049634A0 (it) 1980-09-09
NZ194895A (en) 1983-07-15
DE3033868A1 (de) 1981-04-02
DK382580A (da) 1981-03-11
ZA805556B (en) 1982-04-28
GB2061922B (en) 1983-12-14
IT1128177B (it) 1986-05-28
US4341777A (en) 1982-07-27
AU6216080A (en) 1981-03-19
JPS5645486A (en) 1981-04-25
FR2464960A1 (fr) 1981-03-20
FR2464960B1 (da) 1984-02-10

Similar Documents

Publication Publication Date Title
JPS5944391A (ja) 新規なセフロキシムエステル
DE69728783T2 (de) Verbesserte arzneimittel
JP2015506361A (ja) 治療化合物および関連する使用方法
NL8005072A (nl) Werkwijze ter bereiding van een antibioticum.
EP3886820B1 (en) Capsule formulations
JPH023690A (ja) 抗生物質の安定性の改良
SE449996B (sv) (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr
BR112015010570B1 (pt) Agentes microbianos, composto e seu uso e composição farmacêutica
SE8003722L (sv) Penicillansyraderivat, kompositioner innehallande dessa penicillansyraderivat samt forfarande for deras framstellning
DE2500386A1 (de) 7-eckige klammer auf d-alpha-amino- alpha-(p-hydroxyphenyl)-acetamido eckige klammer zu-3-(1,2,3-triazol-5-yl-thiomethyl)-3-cephem.4.carbonsaeure-1,2-propylen-glykolat, verfahren zur herstellung und arzneimittel
US2857312A (en) Esters of erythromycin and carbomycin
EP0180372B1 (en) Crystalline cephalosporin antibiotics
DE2718730A1 (de) Cephalosporin-antibiotika
CN101884633B (zh) 一种β-内酰胺类抗生素溶液剂及其制备方法
BR112019014825A2 (pt) Composição farmacêutica compreendendo um derivado de oxazina e seu uso no tratamento ou prevenção da doença de alzheimer
Durairaj et al. Establishment of Histomonas meleagridis challenge model in turkeys: An industry perspective.
CN109251189B (zh) 3位哌嗪基查尔酮衍生物、其药物组合物及其应用
CN101926800B (zh) 含有氨力农的药用组合物及其制备方法和应用
CN113307768B (zh) 喹诺酮类衍生物及其制备方法和用途
Sayed et al. Pharmacokinetics and tissue residues of cephradine in healthy and experimentally Salmonella entretidis infected broiler chickens
JP2007503447A (ja) 神経治療セファゾリン経口投与組成物
HU195732B (en) Procecc for the production of medical composition applicable for rectal dosage
CN116063227A (zh) 截短侧耳素衍生物及其合成方法和应用
CN116270635A (zh) 杂环化合物用于减轻化疗药物引起的不良反应的用途
JPS59128390A (ja) セフアロスポリン誘導体及び該誘導体を含有する薬剤

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed